Eganelisib
| Eganelisib | |
|---|---|
| INN | |
| Drug class | |
| Routes of administration | |
| Pregnancy category | |
| Bioavailability | |
| Metabolism | |
| Elimination half-life | |
| Excretion | |
| Legal status | |
| CAS Number | |
| PubChem | |
| DrugBank | |
| ChemSpider | |
| KEGG | |
Eganelisib (also known as IPI-549) is an investigational drug that is being studied for its potential use in cancer treatment. It is a selective inhibitor of the PI3K-gamma enzyme, which plays a role in the immune system and tumor microenvironment.
Mechanism of Action[edit]
Eganelisib works by inhibiting the PI3K-gamma enzyme, which is involved in the regulation of immune cell activity within the tumor microenvironment. By targeting this enzyme, Eganelisib aims to modulate the immune response to enhance the body's ability to fight cancer.
Clinical Trials[edit]
Eganelisib is currently undergoing clinical trials to evaluate its safety and efficacy in combination with other cancer therapies. These trials are exploring its use in various types of cancer, including breast cancer, lung cancer, and melanoma.
Research and Development[edit]
Eganelisib is being developed by Infinity Pharmaceuticals, a company focused on the development of novel cancer therapies. The drug is part of a broader effort to develop targeted therapies that can improve outcomes for patients with cancer.
See Also[edit]
References[edit]
<references />
External Links[edit]
- [Infinity Pharmaceuticals Website](https://www.infi.com)
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
